Literature DB >> 20117265

A decline in varicella but an uncertain impact on zoster following varicella vaccination in Victoria, Australia.

Kylie S Carville1, Michaela A Riddell, Heath A Kelly.   

Abstract

Varicella vaccine was licensed in Australia in 1999 and publicly funded in 2005. We examined trends in varicella and zoster hospitalisations and community consultations in Victoria during periods of no vaccine, private availability of vaccine and funded vaccination. Varicella hospitalisation rates declined 7% per year (95% CI 5-9%) from 2000 to 2007, predominately in children under five (12% per year, 95% CI 9-16%). A similar decline was seen in community data. The zoster hospitalisation rate increased from 1998 to 2007 (5% per year, 95% CI 3-6%), before introduction of varicella vaccine. Among those aged 80 and over the hospitalisation rate increased 5% per year (95% CI 3-7%) from 1998 to 2007. Zoster increased in community data from 2001. Copyright 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20117265     DOI: 10.1016/j.vaccine.2010.01.036

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  19 in total

Review 1.  Successes and challenges in varicella vaccine.

Authors:  Orestis Papaloukas; Georgia Giannouli; Vassiliki Papaevangelou
Journal:  Ther Adv Vaccines       Date:  2014-03

2.  Safety and immunogenicity of Bio Pox™, a live varicella vaccine (Oka strain) in Indian children: A comparative multicentric, randomized phase II/III clinical trial.

Authors:  Anand Prakash Dubey; Mohammad Moonis Akbar Faridi; Monjori Mitra; Iqbal Rajinder Kaur; Aashima Dabas; Jaydeep Choudhury; Mallar Mukherjee; Devendra Mishra
Journal:  Hum Vaccin Immunother       Date:  2017-05-16       Impact factor: 3.452

3.  Digital epidemiology reveals global childhood disease seasonality and the effects of immunization.

Authors:  Kevin M Bakker; Micaela Elvira Martinez-Bakker; Barbara Helm; Tyler J Stevenson
Journal:  Proc Natl Acad Sci U S A       Date:  2016-05-31       Impact factor: 11.205

4.  Varicella and herpes zoster hospitalizations before and after implementation of one-dose varicella vaccination in Australia: an ecological study.

Authors:  Anita E Heywood; Han Wang; Kristine K Macartney; Peter McIntyre
Journal:  Bull World Health Organ       Date:  2014-06-13       Impact factor: 9.408

Review 5.  Varicella vaccination - the global experience.

Authors:  Peter Wutzler; Paolo Bonanni; Margaret Burgess; Anne Gershon; Marco Aurélio Sáfadi; Giacomo Casabona
Journal:  Expert Rev Vaccines       Date:  2017-07-13       Impact factor: 5.217

6.  Severe perianal shingles during azathioprine and budesonide treatment for Crohn's disease-preventable with zoster vaccine?

Authors:  Timothy Ross Elliott; Charles Miller; Finlay A Macrae
Journal:  BMJ Case Rep       Date:  2016-07-20

7.  Influence of frequent infectious exposures on general and varicella-zoster virus-specific immune responses in pediatricians.

Authors:  Benson Ogunjimi; Evelien Smits; Steven Heynderickx; Johan Van den Bergh; Joke Bilcke; Hilde Jansens; Ronald Malfait; Jose Ramet; Holden T Maecker; Nathalie Cools; Philippe Beutels; Pierre Van Damme
Journal:  Clin Vaccine Immunol       Date:  2014-01-15

8.  A spot of bother: Why varicella vaccine programs matter.

Authors:  T Harris; C Y Seo; E Shing; K Wong; J Fediurek; S L Deeks
Journal:  Can Commun Dis Rep       Date:  2015-10-01

Review 9.  Herpes Zoster Risk Reduction through Exposure to Chickenpox Patients: A Systematic Multidisciplinary Review.

Authors:  Benson Ogunjimi; Pierre Van Damme; Philippe Beutels
Journal:  PLoS One       Date:  2013-06-21       Impact factor: 3.240

10.  Varicella routine vaccination and the effects on varicella epidemiology - results from the Bavarian Varicella Surveillance Project (BaVariPro), 2006-2011.

Authors:  Andrea Streng; Veit Grote; David Carr; Christine Hagemann; Johannes G Liese
Journal:  BMC Infect Dis       Date:  2013-07-02       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.